Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2019 | 08-2019 | 05-2019 | 02-2019 | 11-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 528 | 149 | 150 | 139 | N/A |
| Accounts receivable | -458 | 831 | -15 | 178 | N/A |
| Accounts payable and accrued liabilities | -528 | N/A | N/A | N/A | -30 |
| Other Working Capital | -1,428 | 1,249 | -688 | -389 | -62 |
| Other Operating Activity | -1,497 | -2,721 | -2,336 | -2,030 | 17 |
| Operating Cash Flow | $-3,384 | $-492 | $-2,889 | $-2,102 | $-74 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,786 | -5,153 | -7,591 | -4,293 | N/A |
| Purchase Sale Intangibles | -59 | -91 | -123 | -67 | N/A |
| Other Investing Activity | 89 | 680 | 0 | -512 | 0 |
| Investing Cash Flow | $-5,755 | $-4,564 | $-7,714 | $-4,872 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -6,094 | -70 | -65 | -58 | N/A |
| Common Stock Issued | N/A | 2,160 | 5,593 | 38,477 | N/A |
| Other Financing Activity | -306 | -1,384 | 7 | -1,663 | 2 |
| Financing Cash Flow | $-399 | $707 | $5,534 | $36,756 | $2 |
| Exchange Rate Effect | -3 | -19 | 3 | N/A | N/A |
| Beginning Cash Position | 26,506 | 30,875 | 35,942 | 6,148 | 107 |
| End Cash Position | 16,964 | 26,506 | 30,875 | 35,942 | 34 |
| Net Cash Flow | $-9,539 | $-4,350 | $-5,069 | $29,782 | $-73 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,384 | -492 | -2,889 | -2,102 | -74 |
| Capital Expenditure | -5,844 | -6,219 | -7,714 | -4,359 | N/A |
| Free Cash Flow | -9,228 | -6,711 | -10,603 | -6,462 | -74 |